Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLS-1027 for Prevention of Severe COVID-19 Pneumonitis
NCT04590547Phase 2Completed
- Sponsor
- GeneOne Life Science, Inc.
- Start
- May 2021
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of zenuzolac in coronavirus disease 2019 (COVID-19), sponsored by GeneOne Life Science, Inc.. Started May 2021; status: completed.
02
Drugs
zenuzolac
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04590547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04590547.